The panelists discussed and shared examples of how payers and providers are collaborating to develop pathway guidelines.
The panelists discussed and shared examples of how payers and providers are collaborating to develop pathway guidelines.
Dr Tischler shared his experience of working with The US Oncology Network, one of the country’s largest networks of community-based oncology practices. While limited, he thinks there is a variety of strong anecdotal experience with pathway implementation within organizations such as US Oncology. These include both stories of success, and those that come with challenges.
Dr Nabhan, shared his personal experience and suggested that current guidelines fail to address the cost factor in pathways. He argued there are no clear defined steps to developing effective pathways. He commented that US Oncology is 1 organization that has begun to approach successful pathway programs.
Dr Malin added that WellPoint is in the early stages of launching its own pathways program. WellPoint recently announced that it would begin to offer oncologists a financial incentive for each patient who receives treatment for breast, colorectal, or lung cancer as specified by 1 of the insurer's recommended regimens. The program will rollout in a handful of states beginning on July 1, 2014, and is expected to be implemented in other states throughout 2015. The pathways selected by WellPoint intend to eliminate unnecessary medical interventions and to promote only the most cost-effective treatments in cancer care.
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Following Roe v Wade Overturn, Research Focuses on Male Contraceptives
May 6th 2024Stephanie T. Page, MD, PhD, UW Medicine Diabetes Institute, presented on ongoing research and growing interest in new male contraceptive options, such as an oral pill and a hormonal transdermal gel, at the American Urological Association 2024 Annual Meeting.
Read More